Physician

Ajaykumar Dhanwada Rao, M.D.

According to 2025 Medicare claims, Ajaykumar Rao, M.D. (NPI: 1932381175) practices endocrinology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is TEMPLE FACULTY PRACTICE PLAN INC (NPI: 1194207134; TIN: 831002191) and primary practice location at 19140-5103.

Rao's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 373 traditional Medicare patients, billed 634 HCPCS/CPT codes, and received $46,947 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 5,493 prescription claims across 656 beneficiaries totaling $2,492,819 in drug costs, led by Ozempic (Semaglutide). DME data shows 342 claims. Open Payments data shows 6 records totaling $4,435. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $13,117 to $46,947. Similarly, Part D prescription costs have risen steadily, from $254,545 to $2,492,819. For DME billing, reported payments rose steadily, from $2,290 to $88,042.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	121	199	$13,117
2016	222	536	$29,006
2017	236	1,014	$29,055
2018	236	529	$36,670
2019	289	563	$41,333
2020	267	495	$38,026
2021	217	353	$28,908
2022	194	345	$29,934
2023	341	530	$44,860
2024	373	634	$46,947

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	177	929	$254,545
2016	284	1,965	$730,168
2017	394	3,172	$1,409,592
2018	403	3,924	$1,702,535
2019	455	4,180	$1,673,162
2020	479	4,534	$1,881,571
2021	476	4,577	$1,994,129
2022	498	4,607	$2,228,215
2023	640	5,752	$3,180,974
2024	656	5,493	$2,492,819

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	17	106	$2,658
2016	59	171	$3,524
2017	67	236	$10,082
2018	85	428	$24,755
2019	113	458	$39,038
2020	87	433	$27,634
2021	79	368	$31,987
2022	54	311	$42,717
2023	86	390	$56,836
2024	69	342	$88,707

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	24	25	$106
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	56	56	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	287	387	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	48	55	$71
82962	Blood glucose (sugar) test performed by hand-held instrument	39	53	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	433	16,234	$514,900
Trulicity	Dulaglutide	398	14,273	$475,445
Jardiance	Empagliflozin	345	14,484	$276,186
Farxiga	Dapagliflozin Propanediol	152	8,440	$151,497
Tymlos	Abaloparatide	57	1,708	$134,573

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	46	257	$81,932
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	17	$3,646
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	12	12	$2,438
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	11	40	$658
A4259	Lancets, per box of 100	N	N/R	16	$34

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$4,435	Corcept Therapeutics
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ajaykumar Dhanwada Rao, M.D.?

Tedicare shows public-source Medicare data for Ajaykumar Dhanwada Rao, M.D. (NPI 1932381175), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ajaykumar Dhanwada Rao, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ajaykumar Dhanwada Rao, M.D.?

Ajaykumar Dhanwada Rao, M.D. is linked to TEMPLE FACULTY PRACTICE PLAN INC (billing NPI 1194207134) in the available physician profile data.

Does Ajaykumar Dhanwada Rao, M.D. have Open Payments data?

Ajaykumar Dhanwada Rao, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.